Cover Image
市場調查報告書

分子診斷的全球市場:2016∼2020年

Global Molecular Diagnostics Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 356773
出版日期 內容資訊 英文 64 Pages
訂單完成後即時交付
價格
Back to Top
分子診斷的全球市場:2016∼2020年 Global Molecular Diagnostics Market 2016-2020
出版日期: 2016年04月18日 內容資訊: 英文 64 Pages
簡介

傳統醫療採用的試行錯誤的技術,被正確且安全、標記的分子誘導型治療取代。其中之一的分子診斷,用分子等級檢測分析DNA和RNA,查出生物化學途徑的變化,可找出疾病的所在和活動。全球分子診斷市場,預計2016∼2020年,以年複合成長率10.38%擴大。

本報告提供全球分子診斷市場現狀與至2020年的成長預測,市場趨勢與課題,各地區趨勢,主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 搭配診斷:有前途的經營模式

第6章 美國的LDT的展望

  • 法律規章要求事項
  • 引進後方案

第7章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第8章 各用途市場市場區隔

  • 感染疾病
  • 腫瘤學檢驗
  • 血液檢驗
  • 遺傳基因檢驗
  • 組織型決策

第9章 各地區市場市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第10章 推動市場的要素

第11章 促進要素的影響

第12章 市場課題

  • 償付問題
  • 低成本產品的威脅
  • 品管和低溫運輸經營管理的問題
  • DTC遺傳基因檢驗伴隨的道德性問題

第13章 促進要素與課題的影響

第14章 市場趨勢

第15章 供應商環境

  • Abbott Diagnostics
  • Hologic
  • Qiagen
  • Roche Diagnostics
  • Siemens Healthcare
  • 其他值得注意的供應商

第16章 附錄

第17章 關於Technavio

圖表

目錄
Product Code: IRTNTR8570

About Molecular Diagnostics

The traditional trial and error techniques that were used in the field of medicine are now being replaced by accurate, safe, marker-assisted, molecular-guided treatments. Molecular diagnostics is one such technique. This is a technique that involves measurement and analysis of DNA and RNA at the molecular level to detect changes in biochemical pathways. The aim of performing these tests is to determine the location of a disease and its activity. Wide scope of application, specificity, and quick turnaround time are factors that are contributing to its importance in the IVD market.

Technavio's analysts forecast the global molecular diagnostics market to grow at a CAGR of 10.38% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global molecular diagnostics market for 2016-2020. To calculate the market size, revenue generated from the sales of equipment such as automated real-time PCR, mass spectroscopy, and DNA sequencing and DNA microarray diagnostic devices, consumables, and reagents is considered.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Molecular Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • Hologic Inc.
  • Qiagen
  • Roche Diagnostics (a division of F. Hoffmann-La Roche Ltd.)
  • Siemens Healthcare GmbH

Other Prominent Vendors

  • AsuraGen
  • Ahram Biosystem
  • Analytik Jena
  • BD
  • Bio-Rad
  • EKF Molecular Diagnostics
  • EMD Millipore
  • HTG Molecular
  • InBios International
  • Maxim Biomedical
  • Mindray
  • Myriad Genetics
  • Ortho Clinical Diagnostics
  • Ras Lifesciences
  • Trivitron Healthcare
  • ThermoFisher Scientific

Market driver

  • Key to cost-effective diagnosis of cancer
  • For a full, detailed list, view our report

Market challenge

  • Reimbursement issues
  • For a full, detailed list, view our report

Market trend

  • Growth of theranostics
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Companion diagnostics: Promising business model

  • Reimbursement scenario

PART 06: Perspective of LDTs in US

  • Requirement of regulatory framework
  • Post implementation scenario

PART 07: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 08: Market segmentation by application

  • Global molecular diagnostics market by infectious disease testing
  • Global molecular diagnostics market by oncological testing
  • Global molecular diagnostics market by blood testing
  • Global molecular diagnostics market by genetic testing
  • Global molecular diagnostics market by tissue typing

PART 09: Geographical segmentation

  • Molecular diagnostics market in Americas
  • Molecular diagnostics market in EMEA
  • Molecular diagnostics market in APAC

PART 10: Market drivers

  • Key to cost-effective diagnosis of cancer
  • Development of molecular POCT
  • Increase in investments in genomics and proteomics research

PART 11: Impact of drivers

PART 12: Market challenges

  • Reimbursement issues
  • Threat of low-cost products
  • Issues with quality control and cold chain management
  • Ethical issues associated with DTC genetic testing

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Growth of theranostics
  • Development of NGS technology and DNA arrays
  • Increase in partnerships
  • Development of personalized medicine

PART 15: Vendor landscape

  • Abbott Diagnostics
  • Hologic
  • Qiagen
  • Roche Diagnostics
  • Siemens Healthcare
  • Other prominent vendors

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Examples of approved companion diagnostics
  • Exhibit 03: Companion diagnostics coverage in the US
  • Exhibit 04: Global molecular diagnostics market 2015-2020 ($ billions)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Segmentation of global molecular diagnostics market by application 2015
  • Exhibit 07: Global molecular diagnostics market by infectious disease testing 2015-2020 ($ billions)
  • Exhibit 08: Global molecular diagnostic market by oncological testing 2015-2020 ($ billions)
  • Exhibit 09: Global molecular diagnostics market by blood testing 2015-2020 ($ billions)
  • Exhibit 10: Global molecular diagnostics market by genetic testing 2015-2020 ($ billions)
  • Exhibit 11: Global molecular diagnostics market by tissue typing 2015-2020 ($ millions)
  • Exhibit 12: Segmentation of global molecular diagnostics market by geography 2015
  • Exhibit 13: Molecular diagnostics market in Americas 2015-2020 ($ billions)
  • Exhibit 14: Molecular diagnostics market in EMEA 2015-2020 ($ billions)
  • Exhibit 15: Molecular diagnostics market in APAC 2015-2020 ($ billions)
  • Exhibit 16: Impact of drivers
  • Exhibit 17: Impact of drivers and challenges
  • Exhibit 18: Global molecular diagnostics market by vendors 2014 and 2015
  • Exhibit 19: Key molecular diagnostic product launches by Roche and Qiagen 2015
  • Exhibit 20: Key takeaways: Abbott Diagnostics
  • Exhibit 21: Key takeaways: Hologic
  • Exhibit 22: Key takeaways: Qiagen
  • Exhibit 23: Key takeaways: Roche Diagnostics
  • Exhibit 24: Key takeaways: Siemens Healthcare
Back to Top